NPI: 1275578064 · OSHKOSH, WI 54904 · Hematology & Oncology Physician · NPI assigned 06/17/2006
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (VP MANAGED HEALTH) |
| NPI Enumeration Date | 06/17/2006 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 77,267 | $1.69M |
| 2019 | 86,335 | $1.94M |
| 2020 | 83,149 | $1.88M |
| 2021 | 118,307 | $2.43M |
| 2022 | 126,996 | $2.72M |
| 2023 | 135,192 | $3.07M |
| 2024 | 105,146 | $2.73M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 27,177 | 23,975 | $1.61M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,965 | 9,234 | $1.54M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 32,703 | 28,977 | $1.50M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 39,696 | 15,966 | $1.38M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17,973 | 16,002 | $880K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 21,510 | 9,101 | $457K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,118 | 6,397 | $452K |
| 80053 | Comprehensive metabolic panel | 26,474 | 19,996 | $451K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,716 | 4,252 | $368K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,624 | 2,735 | $303K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,034 | 3,606 | $300K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,631 | 3,177 | $297K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4,921 | 3,178 | $265K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,363 | 8,237 | $264K |
| 64493 | 1,147 | 927 | $251K | |
| 97161 | 5,982 | 5,577 | $243K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 33,452 | 24,232 | $214K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,704 | 4,250 | $197K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,295 | 1,277 | $195K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,826 | 1,716 | $189K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,419 | 2,962 | $186K |
| 64494 | 1,459 | 789 | $185K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,284 | 2,081 | $173K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 840 | 797 | $172K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,981 | 1,779 | $156K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,071 | 2,470 | $144K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,558 | 1,395 | $132K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,197 | 1,268 | $130K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,590 | 5,915 | $126K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,470 | 1,481 | $116K |
| 83880 | 3,569 | 3,031 | $113K | |
| 71046 | Radiologic examination, chest; 2 views | 7,080 | 6,482 | $113K |
| 84484 | 9,929 | 8,189 | $108K | |
| 64635 | 563 | 429 | $94K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 585 | 543 | $90K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,401 | 1,294 | $81K |
| 64636 | 552 | 417 | $80K | |
| 97162 | 2,343 | 2,200 | $78K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,983 | 1,709 | $77K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,909 | 1,762 | $77K |
| 81025 | 6,872 | 6,039 | $70K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,078 | 1,882 | $70K |
| 82962 | 7,629 | 4,619 | $67K | |
| 73630 | 3,531 | 3,029 | $61K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,347 | 2,227 | $60K |
| 83690 | 10,089 | 8,388 | $60K | |
| 82077 | 2,704 | 2,239 | $58K | |
| 83735 | 11,015 | 8,046 | $58K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,038 | 4,471 | $57K |
| 93356 | 521 | 501 | $57K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,322 | 1,321 | $56K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 141 | 132 | $55K |
| 93975 | 1,351 | 1,228 | $54K | |
| 62323 | 336 | 316 | $53K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 808 | 713 | $49K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 430 | 397 | $49K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 846 | 741 | $46K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 213 | 195 | $43K |
| 97165 | 1,308 | 1,201 | $43K | |
| 97035 | 3,671 | 1,704 | $41K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,144 | 1,048 | $41K |
| 83605 | 4,188 | 3,557 | $40K | |
| 84145 | 2,032 | 1,729 | $40K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 379 | 338 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,843 | 2,491 | $39K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,161 | 1,064 | $39K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 949 | 873 | $39K |
| G0378 | Hospital observation service, per hour | 2,985 | 2,577 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 741 | 496 | $37K |
| 93971 | 1,241 | 1,158 | $36K | |
| 81001 | 9,451 | 8,328 | $36K | |
| 73610 | 2,229 | 1,973 | $35K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 519 | 454 | $35K |
| 76830 | Ultrasound, transvaginal | 1,131 | 1,035 | $34K |
| 84703 | 3,079 | 2,726 | $33K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5,363 | 4,801 | $32K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 14,025 | 10,627 | $32K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,147 | 1,033 | $30K |
| 85379 | 3,480 | 3,112 | $28K | |
| 82803 | 1,341 | 1,159 | $26K | |
| 97116 | 2,176 | 1,250 | $26K | |
| 86140 | 4,652 | 3,788 | $23K | |
| 93017 | 746 | 698 | $23K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 307 | 292 | $23K |
| 74018 | 1,180 | 1,021 | $22K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 1,618 | 925 | $22K |
| 73030 | 1,777 | 1,555 | $21K | |
| 87040 | 1,690 | 1,378 | $21K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,647 | 1,559 | $20K |
| 87081 | 427 | 396 | $19K | |
| 73110 | 1,111 | 1,005 | $18K | |
| 81003 | 4,176 | 3,735 | $18K | |
| 80047 | 547 | 505 | $18K | |
| 73130 | 1,452 | 1,174 | $17K | |
| 86850 | 949 | 823 | $17K | |
| 85610 | 4,563 | 3,672 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 359 | 346 | $17K |
| 72100 | 1,379 | 1,307 | $16K | |
| 96367 | 281 | 201 | $15K | |
| 0240U | 487 | 451 | $15K | |
| 76536 | 401 | 366 | $14K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 47 | 43 | $14K |
| 71250 | 511 | 480 | $14K | |
| 80143 | 1,225 | 1,003 | $14K | |
| 87077 | 977 | 877 | $14K | |
| 82330 | 1,133 | 972 | $14K | |
| 80179 | 1,191 | 979 | $13K | |
| 70498 | 149 | 130 | $13K | |
| 73564 | 1,025 | 921 | $13K | |
| 84702 | 786 | 670 | $13K | |
| 85730 | 2,743 | 2,414 | $12K | |
| 95886 | 240 | 225 | $12K | |
| 72141 | 174 | 168 | $12K | |
| 94729 | 663 | 605 | $11K | |
| 87210 | 1,221 | 1,119 | $11K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 310 | 297 | $10K |
| 76642 | 293 | 259 | $10K | |
| 87186 | 1,296 | 1,176 | $10K | |
| 63650 | 34 | 12 | $10K | |
| 85027 | 1,698 | 1,245 | $9K | |
| 73562 | 853 | 723 | $9K | |
| 94726 | 625 | 569 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,748 | 4,975 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 495 | 460 | $8K |
| 87070 | 616 | 474 | $8K | |
| 70496 | 67 | 57 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 447 | 389 | $7K |
| 97166 | 224 | 206 | $7K | |
| 73502 | 692 | 650 | $7K | |
| 73140 | 410 | 366 | $7K | |
| 97597 | 240 | 127 | $7K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,401 | 1,374 | $7K |
| 74019 | 228 | 214 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 41 | 37 | $6K |
| 12001 | 84 | 79 | $6K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 82 | 73 | $6K |
| 84132 | 1,184 | 1,022 | $6K | |
| 71045 | Radiologic examination, chest; single view | 8,260 | 7,262 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 15,012 | 12,630 | $5K |
| 93308 | 40 | 38 | $5K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 5,307 | 3,680 | $5K |
| 76770 | 79 | 76 | $5K | |
| 27096 | 26 | 26 | $4K | |
| 86900 | 1,164 | 1,005 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,538 | 3,372 | $4K |
| 80076 | 558 | 507 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,717 | 11,227 | $4K |
| 85652 | 1,741 | 1,403 | $4K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 90 | 84 | $3K |
| 82728 | 326 | 283 | $3K | |
| 29581 | 48 | 12 | $3K | |
| 86901 | 1,161 | 1,005 | $3K | |
| 97535 | Self-care/home management training, each 15 minutes | 300 | 196 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,995 | 9,029 | $2K |
| 73080 | 211 | 198 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 6,572 | 4,633 | $2K |
| 94060 | 73 | 66 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 26 | 24 | $2K |
| 87205 | 798 | 611 | $2K | |
| 87088 | 307 | 290 | $2K | |
| 96415 | 32 | 24 | $2K | |
| 76801 | 79 | 68 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,422 | 586 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 237 | 201 | $2K |
| 70486 | 55 | 54 | $2K | |
| 77002 | 47 | 39 | $1K | |
| 90715 | 57 | 50 | $1K | |
| 93970 | 41 | 37 | $1K | |
| 93922 | 27 | 25 | $1K | |
| 82550 | 242 | 200 | $1K | |
| Q3014 | Telehealth originating site facility fee | 18 | 17 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 11,862 | 10,085 | $1K |
| 73660 | 75 | 61 | $1K | |
| 93880 | 25 | 25 | $1K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 26 | 26 | $1K |
| 87807 | 72 | 71 | $1K | |
| 83550 | 171 | 154 | $982.49 | |
| 87075 | 190 | 132 | $967.87 | |
| 71271 | 14 | 13 | $855.23 | |
| 71101 | 83 | 77 | $825.77 | |
| 95913 | 26 | 25 | $807.68 | |
| 20999 | 22 | 13 | $770.00 | |
| 83540 | 176 | 158 | $761.39 | |
| 73221 | 15 | 15 | $638.48 | |
| 72110 | 28 | 25 | $579.46 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,902 | 2,685 | $576.61 |
| 80061 | Lipid panel | 62 | 54 | $560.39 |
| 97760 | 28 | 25 | $534.08 | |
| 96376 | 3,640 | 2,542 | $500.35 | |
| 90686 | 40 | 36 | $495.44 | |
| 82150 | 75 | 71 | $493.74 | |
| 73590 | 55 | 50 | $420.07 | |
| 72146 | 12 | 12 | $409.06 | |
| 85014 | 234 | 192 | $391.91 | |
| 83615 | 96 | 69 | $319.72 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,562 | 6,449 | $315.80 |
| 94010 | 55 | 50 | $290.84 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 93 | 82 | $272.36 |
| 82607 | 26 | 24 | $239.94 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 234 | 202 | $202.00 |
| 82010 | 27 | 25 | $200.76 | |
| 72040 | 12 | 12 | $188.04 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,472 | 2,971 | $181.76 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 597 | 458 | $168.13 |
| 73560 | 15 | 12 | $158.25 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 143 | 109 | $158.07 |
| J1644 | Injection, heparin sodium, per 1000 units | 960 | 486 | $156.15 |
| 82746 | 13 | 12 | $141.27 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,426 | 1,555 | $138.63 |
| 74022 | 73 | 67 | $136.50 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,705 | 3,102 | $134.59 |
| J7030 | Infusion, normal saline solution , 1000 cc | 14,702 | 10,927 | $119.37 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,821 | 1,347 | $115.28 |
| 84100 | 26 | 12 | $104.86 | |
| 84295 | 28 | 25 | $96.13 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 318 | 288 | $91.95 |
| 36415 | Collection of venous blood by venipuncture | 5,658 | 3,950 | $81.57 |
| C1769 | Guide wire | 976 | 892 | $72.45 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,426 | 2,680 | $69.78 |
| 82272 | 16 | 12 | $51.55 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 963 | 893 | $47.91 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 538 | 424 | $43.70 |
| 82947 | 13 | 12 | $41.33 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,474 | 1,877 | $35.40 |
| 88304 | 137 | 127 | $32.93 | |
| J2060 | Injection, lorazepam, 2 mg | 2,146 | 1,713 | $31.21 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,318 | 9,246 | $26.30 |
| 72072 | 12 | 12 | $25.91 | |
| J7050 | Infusion, normal saline solution, 250 cc | 5,087 | 2,305 | $25.79 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,055 | 940 | $19.69 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 687 | 552 | $16.66 |
| J2704 | Injection, propofol, 10 mg | 10,895 | 7,755 | $16.51 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,574 | 7,855 | $14.26 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,953 | 6,786 | $10.78 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 244 | 210 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 1,979 | 710 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 2,021 | 1,777 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,572 | 1,410 | $0.00 |
| 51798 | 12 | 12 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 660 | 571 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 287 | 241 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 202 | 192 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 1,182 | 1,079 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 877 | 449 | $0.00 |
| 36000 | 290 | 276 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 359 | 254 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 508 | 423 | $0.00 |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 347 | 297 | $0.00 |
| A6223 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing | 54 | 35 | $0.00 |
| J3590 | Unclassified biologics | 146 | 53 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 193 | 175 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 263 | 157 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 32 | 31 | $0.00 |
| J3490 | Unclassified drugs | 232 | 122 | $0.00 |
| A4364 | Adhesive, liquid or equal, any type, per oz | 13 | 12 | $0.00 |
| 80320 | 13 | 12 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 17 | 13 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 12 | 12 | $0.00 |
| C1778 | Lead, neurostimulator (implantable) | 12 | 12 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 35 | 28 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 19 | 12 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 17 | 14 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,453 | 1,043 | $0.00 |
| A4212 | Non-coring needle or stylet with or without catheter | 571 | 298 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 768 | 704 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 448 | 383 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 264 | 142 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,051 | 902 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,841 | 1,555 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 20 | 12 | $0.00 |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 469 | 184 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 226 | 207 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 298 | 264 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 40 | 28 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 184 | 172 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 998 | 624 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,148 | 1,034 | $0.00 |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 155 | 114 | $0.00 |
| 76376 | 58 | 56 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 15 | 12 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 74 | 56 | $0.00 |
| A4565 | Slings | 39 | 36 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 17 | 15 | $0.00 |
| A6206 | Contact layer, sterile, 16 sq. in. or less, each dressing | 36 | 15 | $0.00 |